NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Most financial advisors will keep their clients away from biotechnology as a sector especially now that we are in a bear market. I didn't invest in Northwest Biotherapeutics with the hope that pensioners would pile into this stock. I am looking at whether management can address global GBM demand. The investors will then follow.

We all know about the cash burn rate. This has been a challenge which management have dealt with for years. As a result of their investment in R&D we have a vaccine which could treat all solid tumors as well as multiple manufacturing processes to meet global demand for the GBM indication. That's $100 billion market cap for newly diagnosed and recurrent patients.

I really think your arguments are elementary distractions as we are already aware of this "risk" you cite which really happens to be a standard business practice in the biotechnology sector.

Those who didn't know about this fact, our R&D expenses, haven't done their due diligence.

They probably shouldn't own this stock.

The reasons I do are below.

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://pubmed.ncbi.nlm.nih.gov/37129737/

http://nwbio.com/wp-content/uploads/NWBT-GBM-Summit-slides-3-15-23.pdf

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671